Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. - Wikidata - awgldk - TriplyDB

Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.

Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q34271108

about

Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner.Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells.Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease.Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis.Exosome-like nanoparticles from intestinal mucosal cells carry prostaglandin E2 and suppress activation of liver NKT cells.Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration.Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ.Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury.Regulation of chronic inflammatory and immune processes by extracellular vesicles.Novel therapeutic targets for nonalcoholic fatty liver disease.Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.The emerging roles of microvesicles in liver diseases.The role of microparticles in chronic obstructive pulmonary disease Extracellular vesicle profiling and their use as potential disease specific biomarker.Cell-derived extracellular vesicles as a platform to identify low-invasive disease biomarkers.Multi-Surface Antigen Staining of Larger Extracellular Vesicles.Circulating RNA: looking at the liver through a frosted glass.Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?Exosomes in liver pathology.Review: the Multiple Roles of Monocytic Microparticles.Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia.Extracellular vesicles in liver pathobiology: Small particles with big impact.Angiogenesis and Fibrogenesis in Chronic Liver Diseases.Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).Exosomes: promising sacks for treating ischemic heart disease?Clinical Significance and Roles in Angiogenesis of Circulating Microparticles in Oral Cancer.Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C.Microparticles: a new perspective in central nervous system disorders.Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure.Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study.Biological roles and potential applications of immune cell-derived extracellular vesicles.Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis.Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.

P2860

Q26764843-91DBC749-66E6-441B-9408-D88B0F6AD87B Q26766533-AD3A8D96-B0C8-486B-8752-35602E0CC385 Q27692035-866B96F3-5220-4FD1-88A1-F1D27B18FC9F Q30701525-17333BEC-542A-4D76-9505-64A3DE2CF453 Q33593809-39D2C4DD-74BD-4051-A52C-B8C5FE4C5F4F Q33807881-442E4577-137F-43D1-9C4C-ABA2F4B9BB83 Q34626474-FC84ACC5-1BAB-4AE0-8C62-B433A305E140 Q34769697-43415160-3BE3-4EF8-A6B8-B72CABAD8079 Q35411076-C51DDE0E-530D-439A-93BC-35D78D2D02C8 Q36083468-E49A4A9A-4CBB-456A-A952-48D34749E86F Q36294146-B2C397A6-C7A2-4C7B-9B0A-6219F7A37E95 Q36407214-DC67AF6D-D015-40BC-B41A-A1147AF443F6 Q36466498-190A8672-F40A-4FF6-9256-73DB564F4E09 Q36507134-B61177D1-43BD-4284-8E0D-7A56A2DF6BC5 Q36737940-27A31AF0-9BD6-495C-AD24-7DBC636F1435 Q38100206-F0EAA3FB-75A2-4FB9-8DB4-3737688CDF55 Q38121574-425AE9EA-D8EE-4C1D-9FC3-ABB6CA6C914E Q38184831-34134B58-4CBB-41B1-93BF-B9A6C42FDDC0 Q38202635-556D3FC6-0C46-4F50-A966-7E82CB8B5CCF Q38250056-9110CDCB-0BA1-4C32-ABDD-5160B7168410 Q38463053-531B61FF-A380-4C8C-87D3-51A716C5EFCD Q38614753-F7C6BD03-4CCF-45E2-AE18-7D36537B8E37 Q38652065-8FC79486-E5E0-4BAB-AFD6-06ACB25BCF6E Q38772737-33E1D385-D251-4FB0-BD07-17EDDB30CAD6 Q38779087-1CFA2150-D9F0-4FFC-B825-541CC34DD133 Q38842491-BC9543F8-0BA1-4142-B5B9-55F235FC64C7 Q38874079-1AAAE01E-2E1C-431A-A154-48634776D1E6 Q38954563-D401CCAA-2DEB-47EC-9777-E1184FCB7D31 Q39140170-E2E7E3B2-2A5E-4077-A5BC-6E6C92BA480E Q39387022-61D8C67B-6288-41FB-8956-2968916C42E2 Q39393326-929A29DC-EC3A-4489-88D8-161B3D2CB3D7 Q39395324-DB1FF7E3-E7B4-4E6E-92B9-18702B3E280B Q39889794-E96423E4-8901-4649-93B1-04C23537A607 Q40061733-4E2E74E0-D327-467C-AFDE-8BA65545DF24 Q41129291-D9A14923-9601-483F-9A97-40D0A51D6850 Q41522512-DD071C67-BADB-42B7-9019-CF818ED93271 Q41625778-BC1B0E0C-65EE-457D-AFD2-64CA70BFF94B Q46193686-C268F4E7-80DD-4588-89E4-E8076E689F1E Q47419610-F069C0E6-FACF-4B26-A4F8-8E523E9A233B Q47768810-CD4991C1-45E3-4098-93CA-6045C3079FC6

P2860

Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q34271108

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Circulating microparticles as ...... nonalcoholic steatohepatitis.

@ast

Circulating microparticles as ...... nonalcoholic steatohepatitis.

@en

Circulating microparticles as ...... nonalcoholic steatohepatitis.

@nl

type

label

Circulating microparticles as ...... nonalcoholic steatohepatitis.

@ast

Circulating microparticles as ...... nonalcoholic steatohepatitis.

@en

Circulating microparticles as ...... nonalcoholic steatohepatitis.

@nl

prefLabel

Circulating microparticles as ...... nonalcoholic steatohepatitis.

@ast

Circulating microparticles as ...... nonalcoholic steatohepatitis.

@en

Circulating microparticles as ...... nonalcoholic steatohepatitis.

@nl

P1433

Q34271108-B62F4EC4-7C90-4D07-BF89-5DD52EF62841

P1476

Q34271108-F3F09C8D-4FD9-4A27-B206-450C9924277C

P2093

Q34271108-53553FC1-2FFA-4E48-8C3F-406B96570F03

Q34271108-6AAB8B62-89AA-40E3-BD38-098D519FBBB1

Q34271108-9AC93D66-73A8-40E6-B7B8-8C91CEBEB098

Q34271108-C0CAC01E-3E1F-4088-A71A-C0F5DEFC2C61

P2860

Q34271108-06F7C802-8660-4A9C-A6D1-0FE1155177DC

Q34271108-09256D29-D430-44CE-8268-E84610A2E5B6

Q34271108-096F8D2E-6E76-46F7-9886-320945791E48

Q34271108-129F8C8C-FD4E-4810-9B6C-35093CFD2844

Q34271108-14D34400-6B02-4F2D-8836-5B4A1CFFD4D2

Q34271108-17514166-42F2-49A2-AFF2-27E4FADF227C

Q34271108-272B8962-419D-427A-8F93-285BCC3F015B

Q34271108-2C74037B-E8CD-4AEE-B830-E7CEA5EC9441

Q34271108-2EA89A94-5794-4782-8572-A704C7DCEE53

Q34271108-2F190442-C107-4FED-ABD7-EEB4641D6C38

P304

Q34271108-1B977181-CFDD-4C7A-9D7D-4ABA0C7CC162

P31

Q34271108-491115A1-994D-4E5F-95FC-BE9EE6FDDC07

P356

Q34271108-64D4DD42-5C91-4C87-B664-E4E928183CDF

P407

Q34271108-F59E0941-896A-4B03-A984-9D2187C1C2C4

P433

Q34271108-0A9BF8EC-545C-44A2-B61F-5FD624C6FF6E

P478

Q34271108-799D44B9-7BAD-44ED-811D-FED528F1BF30

P50

Q34271108-032CD741-809F-4E90-AD32-EB9BC61181CD

Q34271108-44B10774-4031-4FB1-B069-9A78DB6FED18

Q34271108-E1A57299-FEA5-46E0-8707-E7F961FD46BB

P577

Q34271108-F06F2619-C344-4DB7-B412-5CBB174F73A2

P5875

Q34271108-97D2C7EB-59D4-4220-8D7D-40359B61D365

P698

Q34271108-B07AF2B5-9EE8-484E-B8A2-1B9C42FCF59C

P921

Q34271108-01FF2170-FF01-4E52-99DA-0B93FB07B595

Q34271108-03C4C859-EDC8-4E06-A400-96D4BF0CA72B

Q34271108-076E5D49-0F2E-45E0-B6D4-076C86CD26C3

Q34271108-3DC2FF3B-1D4A-400E-8AA8-68D1908F9C00

P932

Q34271108-A9C75898-278B-4879-9C55-0BD5A36770B8

P356

J.GASTRO.2012.04.031

P1433

Gastroenterology

P1476

Circulating microparticles as ...... r nonalcoholic steatohepatitis

@en

P2093

Detlef Schuppan

http://www.w3.org/2001/XMLSchema#string

Michael Lynch

http://www.w3.org/2001/XMLSchema#string

Michelle Lai

http://www.w3.org/2001/XMLSchema#string

Shruti H Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

Platelets amplify inflammation in arthritis via collagen-dependent microparticle production

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

ExoCarta: A compendium of exosomal proteins and RNA

Membrane vesicles as conveyors of immune responses

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.

Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria.

P304

448-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2012.04.031

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

Miroslaw Kornek

P577

2012-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224853965

http://www.w3.org/2001/XMLSchema#string

P698

22537612

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

3404266

http://www.w3.org/2001/XMLSchema#string